第三支动脉桥血管至右冠状动脉循环能否改善生存
该回顾性、单中心、倾向性匹配研究纳入2004至2014年三支血管病变行冠状动脉旁路移植术且左循环至少2支动脉桥、右循环第三支为动脉或静脉桥的患者,167对倾向性匹配比较第三支动脉与静脉桥对早中期生存的影响。多因素分析显示第三支动脉桥非生存改善的显著预测因素(HR,0.72;95%CI,0.34-1.55;P=.411),匹配组1年、5年、7年生存率均无显著差异。
要点
- 第三支动脉桥至右循环非生存改善的显著预测因素(HR,0.72;95%CI,0.34-1.55;P=.411)。
- 30天死亡率两组均为0.6%。
- 匹配组1年、5年、7年生存率静脉 vs 动脉分别为99.2% vs 99.2%(P=1.000)、85.2% vs 88.8%(P=.248)、69.2% vs 88.8%(P=.297),均无显著差异。
核心结论
- 本研究显示,在三支血管冠状动脉病变中,与静脉桥相比,第三支动脉桥至右循环未改善长达7年的早中期生存。
- 原文指出可能需要更长随访和更大队列才能显现差异。
研究设计与样本
- 回顾性、单中心、倾向性匹配研究,数据收集自2004至2014年。
- 纳入所有三支血管病变外科血运重建、左循环至少2支动脉桥、右循环第三支为动脉或静脉桥的患者。
- 共167对倾向性匹配比较第三支动脉与静脉桥至右循环。
主要发现
- 心外动脉病变、logistic euroSCORE和左主干病变是不良生存的显著预测因素。
- 第三支动脉桥至右循环在多因素分析中非生存改善的显著预测因素(HR,0.72;95%CI,0.34-1.55;P=.411)。
- 30天死亡率两组均为0.6%。
- 倾向性匹配组早期或中期生存无显著差异:1年静脉 vs 动脉99.2% vs 99.2%(P=1.000);5年85.2% vs 88.8%(P=.248);7年69.2% vs 88.8%(P=.297)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The long-term benefits of a third arterial conduit to the right circulation in triple-vessel disease remain debatable. This retrospective, single-center, propensity-matched study investigates the impact of a third arterial conduit to the right circulation on early and intermediate survival after coronary artery bypass grafting. METHODS: Data were retrospectively collected from 2004 to 2014 for all surgical revascularizations for triple-vessel disease with at least 2 arterial conduits to the left circulation and a third arterial or venous conduit to the right circulation. A total of 167 pairs were propensity matched to arterial versus venous third conduit to right circulation. Hazard functions were obtained with Cox multivariate regression and Kaplan-Meier survival curves were compared between the matched cohorts. RESULTS: Extracardiac arteriopathy, logistic euroSCORE, and left main stem disease were significant predictors of adverse survival. A third arterial conduit to the right circulation was not a significant predictor of improved survival in multivariate analysis (HR, 0.72; 95% CI, 0.34-1.55; P = .411). 30-day mortality was 0.6% in both groups. There was no significant difference in early or intermediate survival in the propensity-matched groups (venous vs arterial, 99.2% vs 99.2%; P = 1.000 at 1 year; 85.2% vs 88.8%; P = .248 at 5 years and 69.2% vs 88.8%; P = .297 at 7 years) CONCLUSIONS: The use of a third arterial versus a venous conduit to the right circulation does not improve early or intermediate survival up to 7 years in triple-vessel coronary artery disease in this study. Longer follow-up and larger cohorts may be needed for differences to emerge.
引用
- Luthra S, Leiva-Juárez MM, Matuszewski M, et al. Does a third arterial conduit to the right coronary circulation improve survival? J Thorac Cardiovasc Surg. 2017. PMID: 29248279. doi:10.1016/j.jtcvs.2017.09.163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。